Bone marrow involvement in cutaneous mastocytosis

被引：16

作者：

Fearfield, LA ^{[1
]}

Francis, N

Henry, K

Costello, C

Bunker, CB

机构：

[1] Chelsea & Westminster Hosp, Dept Dermatol, London SW10 9NH, England

[2] Chelsea & Westminster Hosp, Dept Haematol, London SW10 9NH, England

[3] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London, England

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2001年 / 144卷 / 03期

关键词：

bone marrow; cutaneous mastocytosis; cytogenetic abnormalities;

D O I：

10.1046/j.1365-2133.2001.04084.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Background Cutaneous mastocytosis is considered a relatively benign and indolent form of mast cell disease, which either ultimately regresses, remains stable or is only slowly progressive. Previously, it has been purported that no more than 60% of adult patients with cutaneous mastocytosis will have occult bone marrow involvement. Objectives To investigate the frequency of bone marrow involvement in patients with mastocytosis but without systemic symptoms. Methods Bone marrow aspirate and trephine biopsy were performed in 13 consecutive patients with cutaneous mastocytosis attending our department. Results All but one of these patients had evidence of bone marrow involvement. Bone marrow cytogenetic abnormalities have been found in patients with cutaneous mastocytosis: all our patients who were analysed showed a normal karyotype. Conclusions Bone marrow involvement is common in adults with cutaneous mastocytosis.

引用

页码：561 / 566

页数：6

共 30 条

[11]

KIRSHENBAUM AS, 1992, J IMMUNOL, V148, P772

[12]

KIRSHENBAUM AS, 1991, J IMMUNOL, V146, P1410

[13] Mastocytosis: Reactive or neoplastic? [J].

Krober, SM ;

Horny, HP ;

Ruck, P ;

Kammerer, U ;

Geiselhart, A ;

Handgretinger, R ;

Greisser, H ;

Menke, DM ;

Kaiserling, E .

JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (06) :525-527

[14]

LEWIS HM, 1995, J ROY SOC MED, V88, P530

[15] Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis [J].

Longley, BJ ;

Metcalfe, DD ;

Tharp, M ;

Wang, XM ;

Tyrrell, L ;

Lu, SZ ;

Heitjan, D ;

Ma, YS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (04) :1609-1614

[16] Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm [J].

Longley, BJ ;

Tyrrell, L ;

Lu, SZ ;

Ma, YS ;

Langley, K ;

Ding, TG ;

Duffy, T ;

Jacobs, P ;

Tang, LH ;

Modlin, I .

NATURE GENETICS, 1996, 12 (03) :312-314

[17] ALTERED METABOLISM OF MAST-CELL GROWTH-FACTOR (C-KIT LIGAND) IN CUTANEOUS MASTOCYTOSIS [J].

LONGLEY, BJ ;

MORGANROTH, GS ;

TYRRELL, L ;

DING, TG ;

ANDERSON, DM ;

WILLIAMS, DE ;

HALABAN, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (18) :1302-1307

[18] IDENTIFICATION OF A POINT MUTATION IN THE CATALYTIC DOMAIN OF THE PROTOONCOGENE C-KIT IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF PATIENTS WHO HAVE MASTOCYTOSIS WITH AN ASSOCIATED HEMATOLOGIC DISORDER [J].

NAGATA, H ;

WOROBEC, AS ;

OH, CK ;

CHOWDHURY, BA ;

TANNENBAUM, S ;

SUZUKI, Y ;

METCALFE, DD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10560-10564

[19]

RODERMUND OE, 1978, DERMATOL MONATSSCHR, V164, P493

[20]

RODERMUND OE, 1980, HAUTARZT, V31, P175

← 1 2 3 →